Touted as “one to watch” in biotech investor circles, German biopharmaceutical company Kupando is advancing a disruptive dual approach that could both reduce solid tumours and counter infectious diseases.
Paris based company Standing Ovation specialises in producing animal-free casein through precision fermentation. They just raised an impressive €30 million as part of French efforts to preserve technical sovereignty and secure future food supply.
UK-Portugal greentech venture Arborea is bridging the gap between design engineering and biotechnology with a synthetic leaf that creates food directly from sunlight.
A New Zealand university spinoff venture has a bold vision to extract and recycle critical minerals from industrial waste.
Touted as “one to watch” in biotech investor circles, German biopharmaceutical company Kupando is advancing a disruptive dual approach that could both reduce solid tumours and counter infectious diseases.
Paris based company Standing Ovation specialises in producing animal-free casein through precision fermentation. They just raised an impressive €30 million as part of French efforts to preserve technical sovereignty and secure future food supply.
UK-Portugal greentech venture Arborea is bridging the gap between design engineering and biotechnology with a synthetic leaf that creates food directly from sunlight.
A New Zealand university spinoff venture has a bold vision to extract and recycle critical minerals from industrial waste.
The 2026 Denholm Review — formally titled Ambitious Australia — issues a blunt wake-up call. The nation’s R&D system is too fragmented and risk-averse to sustain future living standards and must transition into a “smart country”.
A spinoff company from the Australian National University plans to shake up the garment industry through enzymatic recycling of polyester.
EU Inc, a new pan-European legal entity structure, proposed by the European Commission, aims to simplify company incorporation, investment and acquisitions for startup ventures across the European Union.
New Zealand deep tech startup Wellumio is developing a portable NMR scanner that delivers quicker patient care and better outcomes.
A Swedish biotech startup is making waves in the field of 3D “spatial biology” for transcriptomics – a game changer for accelerated development of drug therapies.
